<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="in-brief"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id><journal-id journal-id-type="hwp">dmm</journal-id><journal-id journal-id-type="publisher-id">DMM</journal-id><journal-title-group><journal-title>Disease Models &#x00026; Mechanisms</journal-title></journal-title-group><issn pub-type="ppub">1754-8403</issn><issn pub-type="epub">1754-8411</issn><publisher><publisher-name>The Company of Biologists Limited</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC3097439</article-id><article-id pub-id-type="publisher-id">0040277d</article-id><article-categories><subj-group subj-group-type="heading"><subject>In This Issue</subject></subj-group></article-categories><title-group><article-title>How hypertrophic cardiomyopathy manifests: clues from development</article-title></title-group><pub-date pub-type="ppub"><month>5</month><year>2011</year></pub-date><volume>4</volume><issue>3</issue><fpage seq="e">277</fpage><lpage>277</lpage><permissions><copyright-statement>Written by editorial staff. &#x000a9; 2011. Published by The Company of Biologists Ltd.</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">http://creativecommons.org/licenses/by-nc-sa/3.0</ext-link>), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="277.pdf"/></article-meta></front><body><p>Hypertrophic cardiomyopathy (HCM) is a monogenic cardiovascular disorder that is caused mainly by mutations in sarcomeric contractile proteins such as cardiac troponin T (TNNT2). Becker et al. create a <italic>tnnt2</italic> zebrafish morphant to study basic mechanisms of HCM pathology and to identify modifiers of the HCM phenotype. Their findings indicate that <italic>tnnt2</italic> deficiency initiates cardiac defects at early developmental stages, including abnormalities in cardiomyocyte calcium handling. These findings suggest that the pathology of HCM might arise during development, before the onset of symptoms.</p><p><bold>Page
<related-article related-article-type="article-reference" id="d32e66" vol="4" page="400" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="21245263" ext-link-type="pubmed">400</related-article></bold></p></body></article>
